Biogen (BIIB) Cash & Current Investments (2009 - 2026)
Biogen's Cash & Current Investments was $1.29 billion in Q2 2026, down 53.4% from $2.76 billion a year earlier and down 70.0% from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) Cash & Current Investments (2009 - 2026) Analysis & Trends
At the end of FY2025, Cash & Current Investments at Biogen came in at $3.82 billion, up 60.7% from FY2024.
- Cash & Current Investments shows a five-year compound annual growth rate of 7.9% (FY2020 to FY2025).
- In earlier years, Cash & Current Investments was $2.38 billion in FY2024 (+126.2%), $1.05 billion in FY2023 (-78.5%), $4.89 billion in FY2022 (+28.7%) and $3.8 billion in FY2021 (+45.7%).
- The Q2 2026 figure marks the lowest quarterly Cash & Current Investments since Q1 2024.
- Compared with a year earlier, Cash & Current Investments was higher in six of the last eight quarters, with growth averaging 61.5%.
- The best year-over-year quarter for Cash & Current Investments over five years was Q1 2025 (growth of 141.8%); the worst was Q1 2024 (a decline of 78.7%).
- Per Business Quant data, BIIB's Cash & Current Investments in the three quarters before Q2 2026 was $4.28 billion (Q1 2026), $3.82 billion (Q4 2025) and $3.96 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Biogen | 37.04 Bn | 23.70 Bn | 1.96 Bn | 1.29 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.29 Bn |
| Mar 31, 2026 | 4.28 Bn |
| Dec 31, 2025 | 3.82 Bn |
| Sep 30, 2025 | 3.96 Bn |
| Jun 30, 2025 | 2.76 Bn |
| Mar 31, 2025 | 2.60 Bn |
| Dec 31, 2024 | 2.38 Bn |
| Sep 30, 2024 | 1.70 Bn |
| Jun 30, 2024 | 1.91 Bn |
| Mar 31, 2024 | 1.07 Bn |
| Dec 31, 2023 | 1.05 Bn |
| Sep 30, 2023 | 2.29 Bn |
| Jun 30, 2023 | 6.08 Bn |
| Mar 31, 2023 | 5.04 Bn |
| Dec 31, 2022 | 4.89 Bn |
| Sep 30, 2022 | 4.91 Bn |
| Jun 30, 2022 | 4.80 Bn |
| Mar 31, 2022 | 3.75 Bn |
| Dec 31, 2021 | 3.80 Bn |
| Sep 30, 2021 | 2.96 Bn |
API Access
Biogen Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();